<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/FC93129A-2862-4E51-9864-108A4AD7A28E"><gtr:id>FC93129A-2862-4E51-9864-108A4AD7A28E</gtr:id><gtr:name>Cn Bio Innovations Limited</gtr:name><gtr:address><gtr:line1>30 UPPER HIGH STREET</gtr:line1><gtr:city>THAME</gtr:city><gtr:postCode>OX9 3EZ</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC93129A-2862-4E51-9864-108A4AD7A28E" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>FC93129A-2862-4E51-9864-108A4AD7A28E</gtr:id><gtr:name>Cn Bio Innovations Limited</gtr:name><gtr:address><gtr:line1>30 UPPER HIGH STREET</gtr:line1><gtr:city>THAME</gtr:city><gtr:postCode>OX9 3EZ</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>149712.0</gtr:offerGrant><gtr:projectCost>299424.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>137880.0</gtr:offerGrant><gtr:projectCost>137880.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B5E08BCA-4EA2-4C62-BC97-B4E40701315A" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>B5E08BCA-4EA2-4C62-BC97-B4E40701315A</gtr:id><gtr:name>Definigen Limited</gtr:name><gtr:address><gtr:line1>100 HILLS ROAD</gtr:line1><gtr:city>CAMBRIDGE</gtr:city><gtr:postCode>CB2 1PH</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>70021.0</gtr:offerGrant><gtr:projectCost>116701.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CAD20777-66AB-4260-A773-FA8000B2C0BB"><gtr:id>CAD20777-66AB-4260-A773-FA8000B2C0BB</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:surname>Driscoll</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=102521"><gtr:id>59CDC5C9-7751-49BD-80A7-70EFEBEC58FF</gtr:id><gtr:title>3D culture model for Non-Alcoholic SteatoHepatitis (NASH) drug discovery</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>102521</gtr:grantReference><gtr:abstractText>NASH presents a significant unmet medical need in more economically developed nations, affecting up to 5% of

the US population alone. There is currently no medical treatment for NASH, where the condition is a precursor

to cirrhosis and hepatocellular carcinoma, conditions with very poor prognoses. One key limiting factor in the

development of a treatment for NASH is a lack of suitable in vitro models. The project will produce a highly

representative, medium throughput, 3D perfused model of NASH using both primary human and induced

pluripotent stem cell derived hepatocytes, kupffer and stellate co-cultures. These models can be used in

collaboration with industry to enable highly effective drug discovery studies and macrosteatotically relevant

ADME/Toxicology studies.</gtr:abstractText><gtr:fund><gtr:end>2017-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2016-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>357613</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">102521</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>